FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, specifically to the production of immunogenic HTT polypeptides, and can be used in medicine.
EFFECT: resulting immunogenic HTT polypeptides can be used to create a vaccine against HTT and to obtain antibodies to HTT used in effective treatment of Huntington's disease or delaying the onset of its clinical symptoms by immunization.
20 cl, 29 dwg, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPY AND DIAGNOSTICS BASED ON PROTEINS OF TAU-MEDIATED PATHOLOGY IN ALZHEIMER DISEASE | 2012 |
|
RU2645259C2 |
| PEPTIDE VACCINES AGAINST INTERLEUKIN-31 | 2019 |
|
RU2786441C2 |
| MUTANT VIRUS OF BULL DIARRHEA | 2006 |
|
RU2394594C2 |
| ANTIBODIES SUITABLE FOR PASSIVE IMMUNIZATION AGAINST INFLUENZA | 2011 |
|
RU2635999C2 |
| COMPOSITIONS RELATED TO CLOSTRIDIUM DIFFICILE MUTANT TOXIN, AND METHODS OF APPLICATION THEREOF | 2012 |
|
RU2592686C2 |
| COMPOSITIONS AND METHODS RELEVANT TO MUTANT TOXIN FROM CLOSTRIDIUM DIFFICILE | 2013 |
|
RU2630671C2 |
| ANTIBODIES USED PASSIVE VACCINATION AGAINST INFLUENZA | 2012 |
|
RU2668802C2 |
| PEPTIDES-DERIVATIVES IL-4 FOR MODULATION OF CHRONIC INFLAMMATORY RESPONSE AND TREATMENT OF AUTOIMMUNE DISEASES | 2009 |
|
RU2542375C2 |
| AGONIST NOTCH3 ANTIBODIES AND APPLICATION THEREOF FOR TREATING NOTCH3-ASSOCIATED DISEASES | 2007 |
|
RU2461569C2 |
| VACCINE | 2012 |
|
RU2640258C2 |
